Loading...
International Biotechnology Trust plc
IBT.L•LSE
Financial Services
Asset Management
£594.64
£0.64(0.11%)
International Biotechnology Trust plc (IBT.L) Financial Performance & Statements
Review International Biotechnology Trust plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
404.86%
↑ 404.86%
Operating Income Growth
470.34%
↑ 470.34%
Net Income Growth
470.62%
↑ 470.62%
Operating Cash Flow Growth
66.13%
↑ 66.13%
Operating Margin
92.23%
↑ 92.23%
Gross Margin
88.67%
↑ 88.67%
Net Profit Margin
90.66%
↑ 90.66%
ROE
13.67%
↑ 13.67%
ROIC
12.91%
↑ 12.91%
International Biotechnology Trust plc (IBT.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for International Biotechnology Trust plc stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $42.88M | $8.49M | -$21.10M | $29.12M |
| Cost of Revenue | $2.74M | $2.32M | $2.48M | $2.75M |
| Gross Profit | $40.14M | $6.17M | -$23.58M | $26.37M |
| Gross Profit Ratio | $0.94 | $0.73 | $1.12 | $0.91 |
| R&D Expenses | $0.00 | $0.00 | -$1.00 | $2.00 |
| SG&A Expenses | $1.13M | $1.56M | $1.22M | $1.07M |
| Operating Expenses | $1.13M | $1.56M | $1.22M | $1.07M |
| Total Costs & Expenses | $1.13M | $1.56M | $1.22M | $1.07M |
| Interest Income | $218000.00 | $23000.00 | $663000.00 | $218000.00 |
| Interest Expense | $2.20M | $1.24M | $663000.00 | $218000.00 |
| Depreciation & Amortization | $0.00 | -$6.59M | $17.28M | -$28.20M |
| EBITDA | $39.55M | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $0.92 | $0.82 | $1.03 | $0.96 |
| Operating Income | $39.55M | $6.93M | -$21.66M | $28.05M |
| Operating Income Ratio | $0.92 | $0.82 | $1.03 | $0.96 |
| Other Income/Expenses (Net) | -$542000.00 | $0.00 | -$5.04M | $0.00 |
| Income Before Tax | $39.01M | $6.93M | -$22.32M | $28.05M |
| Income Before Tax Ratio | $0.91 | $0.82 | $1.06 | $0.96 |
| Income Tax Expense | $135000.00 | $122000.00 | $151000.00 | $162000.00 |
| Net Income | $38.88M | $6.81M | -$22.47M | $27.89M |
| Net Income Ratio | $0.91 | $0.80 | $1.06 | $0.96 |
| EPS | $1.02 | $0.17 | -$0.55 | $0.69 |
| Diluted EPS | $1.02 | $0.17 | -$0.55 | $0.69 |
| Weighted Avg Shares Outstanding | $38.18M | $40.58M | $41.07M | $40.50M |
| Weighted Avg Shares Outstanding (Diluted) | $38.18M | $40.58M | $41.07M | $40.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan